Linda Jkarr is an accomplished Global Program Manager at Genentech, where she plays a pivotal role in shaping the future of drug development through her expertise in Portfolio Strategy and Execution. With a robust background in Chemistry, Manufacturing, and Controls (CMC), Linda has successfully led...
Linda Jkarr is an accomplished Global Program Manager at Genentech, where she plays a pivotal role in shaping the future of drug development through her expertise in Portfolio Strategy and Execution. With a robust background in Chemistry, Manufacturing, and Controls (CMC), Linda has successfully led global project management teams and navigated complex Business Operations for Technical Development across all phases of clinical development and supply. Her strategic acumen is particularly evident in her current position as Chief of Staff and strategic thought partner for Lifecycle Teams, where she drives late-stage drug development programs aimed at maximizing portfolio value and enhancing patient outcomes.
In her role, Linda is instrumental in accelerating informed decision-making processes, fostering effective collaboration, and catalyzing transformative change within the organization. Her experience encompasses critical phases of clinical development, including phase 2/3 trials and post-launch initiatives, where she leverages her deep understanding of regulatory compliance, particularly 21 CFR Part 11, to ensure that all projects adhere to the highest quality standards.
Linda's exceptional communication and organizational skills enable her to navigate the complexities of the pharmaceutical industry with ease, while her commitment to process improvement and project management ensures that her teams operate at peak efficiency. As a thought leader in the biotech sector, she continuously seeks innovative solutions to enhance drug development workflows and drive successful outcomes, ultimately benefiting both the portfolio and the patients who rely on these life-changing therapies.
